This is a StreetInsider.com Premium Only Page

Athersys (ATHX) – StreetInsider.com Reports

Nov 17, 2023 06:36 AM Athersys (ATHX) Tops Q3 EPS by 6c

Nov 9, 2023 05:15 PM Athersys (ATHX) Announces 76.25M Share Offering by Selling Stockholders

Oct 16, 2023 04:52 PM Athersys (ATHX) Extends Near Term Liquidity with Proceeds from Warrant Inducement and Global ARDS License with Healios to Explore Strategic Alternatives

Oct 10, 2023 08:25 AM Athersys (ATHX) Halted, News Pending

Oct 3, 2023 04:31 PM Athersys (ATHX) Licenses Animal Health Assets to Ardent Animal Health

Oct 2, 2023 05:06 PM Athersys (ATHX) Director Jane Wasman Appointed Board Chair

Sep 13, 2023 05:16 PM Athersys (ATHX) Announces 15.36M Share Offering by Selling Stockholders

Aug 18, 2023 05:42 AM Athersys (ATHX) Prices 10.94M Share Offering at $0.32/sh

Aug 16, 2023 05:33 PM Athersys (ATHX) Misses Q2 EPS by 33c

Aug 16, 2023 05:01 PM Athersys (ATHX) Reports Q2, Provides Updates

Aug 11, 2023 08:01 AM Athersys (ATHX) Appoints Neema Mayhugh to its Board

Apr 28, 2023 03:52 PM Athersys (ATHX) Announces 11.03M Share Offering by Selling Stockholders

Apr 18, 2023 08:06 AM Athersys (ATHX) Announces 3.7M Share Offering at $1/sh

Apr 4, 2023 06:09 AM Athersys (ATHX) Files $250M Mixed Shelf

Mar 22, 2023 08:30 AM Athersys (ATHX) Announces Successful Type B Meeting with the FDA

Mar 6, 2023 07:16 AM Alliance Global Partners Starts Athersys (ATHX) at Buy

Feb 14, 2023 08:34 AM Athersys (ATHX) Granted Clinical Type B Meeting with FDA for MASTERS-2 Clinical Trial Protocol Discussion

Jan 9, 2023 08:34 AM Athersys (ATHX) Provides MultiStem Clinical Update

Jan 5, 2023 04:33 PM Athersys (ATHX) Appoints Joseph Nolan to Its Board

Nov 9, 2022 04:41 PM U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.95%

Nov 9, 2022 04:35 PM U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.95%

Nov 9, 2022 08:59 AM Athersys (ATHX) Prices 5M Share Offering at $1.10/sh

Nov 7, 2022 04:19 PM Athersys (ATHX) Announces Proposed Public Offering

Nov 1, 2022 08:53 AM Athersys (ATHX) Announces Resignation of Kenneth H. Traub from Board

Sep 30, 2022 03:38 AM Implied Volatility Movement

Sep 26, 2022 04:19 AM Implied Volatility Movement

Sep 23, 2022 09:20 AM Athersys (ATHX) Amends Securities Purchase Agreement in Connection with Recent Registered Direct Offering

Aug 26, 2022 09:12 AM Pre-Open Movers: Workday, Farfetch Gain on EPS; Seagen Falls on Deal Worries

Aug 25, 2022 05:52 PM After-Hours Movers: Workday Jumps on Strong EPS; Affirm, Dell Fall on Weak Results

Aug 25, 2022 04:32 PM Athersys (ATHX) Announces 1:25 Reverse Stock Split

Aug 15, 2022 08:31 AM Athersys (ATHX) Prices 48M Share Direct Offering at $0.25/sh

Aug 8, 2022 09:40 AM Athersys (ATHX) Announces Favorable Preclinical Results for MultiStem Treatment in Defense Department Radiation Countermeasure Study

Aug 4, 2022 08:01 AM Athersys (ATHX) Appoints Kasey Rosado as Interim CFO

Jul 8, 2022 07:30 AM Athersys (ATHX) and Aspire Capital Fund Terminate Relationship

Jun 9, 2022 07:03 AM Athersys (ATHX) Postpones Annual Meeting of Stockholders

May 23, 2022 05:04 AM BofA Securities Downgrades Athersys (ATHX) to Underperform

May 20, 2022 05:53 AM Athersys (ATHX) Announces That HEALIOS Reports Topline Data From the TREASURE Multistem Ischemic Stroke Study

May 6, 2022 08:03 AM Athersys (ATHX) Tops Q1 EPS by 1c

May 5, 2022 05:29 PM Athersys (ATHX) Files $250M Mixed Shelf

Apr 11, 2022 03:44 PM Athersys (ATHX) Climbs 100%

Apr 4, 2022 08:50 AM Dawson James Reiterates Buy Rating, $7 PT on Athersys (ATHX), Continues to See Company as Undervalued

Apr 4, 2022 07:17 AM Athersys (ATHX) Reports That Its Partner, HEALIOS K.K., Provides Updates on MultiStem® Clinical Programs in Japan

Mar 17, 2022 11:14 AM Athersys (ATHX) CEO Buys ~133K Shares

Mar 16, 2022 09:25 AM Dawson James Reiterates Buy Rating, $7 PT on Athersys (ATHX), Sees Company as Undervalued Upon Success of Clinical Trials

Mar 16, 2022 06:16 AM Needham & Company Reiterates Athersys (ATHX) at Buy, TREASURE Study Remains Key Catalyst, but Limited Cash Poses Significant Overhang

Mar 16, 2022 05:45 AM Athersys (ATHX) PT Lowered to $1 at BofA Securities

Mar 15, 2022 04:12 PM Athersys (ATHX) Misses Q4 EPS by 2c

Feb 3, 2022 07:57 AM All Focus on Athersys' (ATHX) Upcoming Readout from Pivotal TREASURE Study, May Strongly Drive Shares - Needham & Company

Jan 21, 2022 05:12 AM Athersys (ATHX) Appoints Daniel A. Camardo as CEO

Nov 30, 2021 06:03 AM Athersys (ATHX) Reports Publication of Data from Placebo-Controlled Clinical Trial Evaluating MultiStem Cell Therapy for Acute Respiratory Distress Syndrome